InvestorsHub Logo
Followers 19
Posts 901
Boards Moderated 0
Alias Born 05/31/2013

Re: trading.jeff post# 47318

Tuesday, 10/22/2019 9:32:40 AM

Tuesday, October 22, 2019 9:32:40 AM

Post# of 48316
I saw this yesterday from jckrdu at biotech inv.:

"One other thing I'll mention is that I did have a conversation with DOC (Dan O'Connor) several months ago. When I asked him about Merck's interest in ONCS, DOC basically said that Merck likes the data, but would only move forward to pull the trigger on a bigger deal (monetary partnership or buyout) if they "had to". When I asked follow-up questions, the response was … that's just the way Merck does their business development... they don't make major moves unless they feel someone else is interested, and their hand is forced.

IMO, this deal with CGP is DOC's way of forcing Merck to make a decision. I'm going to hold until we see how the story ends. I think it ends higher than $4.50 with multiple parties appearing to be interested (Alpha, CGP and Merck) and the institutional investors still holding."